PTGS2 and non-small cell lung carcinoma: In NSCLC A549 cells, COX-2-derived PGE2 promotes cell migration, cell proliferation and apoptosis resistance, and COX-2 inhibition suppresses cell proliferation associating with inhibition of survivin expression and increased caspase-3 mediated apoptosis [39–41].